Medicus Pharma Ltd. — Director's Dealing 2025

Aug 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-08-13

Reporting Person: Quinlan James P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-13	Common Shares, no par value ("Common Shares")	M	125000	$0.81	Acquired	254147	Direct
2025-08-13	Common Shares	M	20000	$2.75	Acquired	274147	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-13	Stock Option (right to buy)	$0.81	M	125000	Disposed	2028-10-24	Common Shares (125000)	Direct
2025-08-13	Stock Option (right to buy)	$2.75	M	20000	Disposed	2029-12-17	Common Shares (20000)	Direct

Footnotes

F1: Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

F2: Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

F3: The option was vested and was exercisable as of the Transaction Date.